`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE NORTHERN DISTRICT OF WEST VIRGINIA
`AT CLARKSBURG
`
`MERCK SHARP & DOHME CORP.,
`
`Plaintiff,
`
`C.A. No. 1:19-cv-00101 (IMK)
`
`v.
`
`MYLAN PHARMACEUTICALS INC.,
`
`Defendant.
`
`AMENDED FINAL JUDGMENT
`
`For the reasons set forth in the Court’s Memorandum Opinion and Order Following
`
`Bench Trial, Dkt. 193, IT IS HEREBY ORDERED THAT:
`
`1.
`
`Pursuant to 35 U.S.C. § 271(e)(4)(A), the effective date of any final approval of
`
`ANDA No. 202473 shall be a date that is not earlier than the latest date of expiration of U.S.
`
`Patent No. 7,326,708, including any extensions or additional periods of exclusivity.
`
`2.
`
`Pursuant to 35 U.S.C. § 271(e)(4)(A), the effective date of any final approval of
`
`ANDA No. 202478 shall be a date that is not earlier than the latest date of expiration of U.S.
`
`Patent Nos. 7,326,708 and 8,414,921, including any extensions or additional periods of
`
`exclusivity.
`
`3.
`
`Judgment is entered in favor of Plaintiff and against Defendant.
`
`Date: _________________
`September 29, 2022
`
`HON. IRENE M. KEELEY
`UNITED STATES DISTRICT JUDGE
`
`